Sandbox:Cherry: Difference between revisions
No edit summary |
|||
| Line 27: | Line 27: | ||
|} | |} | ||
== | ==Pathophysiology== | ||
==Diagnosis== | ==Diagnosis== | ||
Revision as of 13:59, 18 October 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sudarshana Datta, MD [2]
Overview
| gkfff | |||
|---|---|---|---|
| blbkgg | df | ||
| bjkb |
Pathophysiology
Diagnosis
Visceral hypersensitivity may have been utilized as a clinical marker of IBS and could be represented by signs and symptoms of urgency for bowel movements, bloating and abdominal pain. The mechanisms that result in persistent visceral hypersensitivity in patients who have IBS are unclear. nonetheless, various working models might be considered
|
Xyz Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Sandbox:Cherry On the Web |
|
American Roentgen Ray Society Images of Sandbox:Cherry |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3]; Associate Editor(s)-in-Chief:
Synonyms and keywords:
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Xyz from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Electrocardiogram | Laboratory Findings | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Diagnostic Studies | Other Imaging Findings
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
- ↑ "api.isoa.org" (PDF).